These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26161999)

  • 41. Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways.
    Danpure CJ
    Biochim Biophys Acta; 2006 Dec; 1763(12):1776-84. PubMed ID: 17027096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunocytochemical localization of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type 1.
    Cooper PJ; Danpure CJ; Wise PJ; Guttridge KM
    J Histochem Cytochem; 1988 Oct; 36(10):1285-94. PubMed ID: 3418107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.
    Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS
    J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A glycine-to-glutamate substitution abolishes alanine:glyoxylate aminotransferase catalytic activity in a subset of patients with primary hyperoxaluria type 1.
    Purdue PE; Lumb MJ; Allsop J; Minatogawa Y; Danpure CJ
    Genomics; 1992 May; 13(1):215-8. PubMed ID: 1349575
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Putative Mutation Hotspot of the AGXT Gene Associated with Primary Hyperoxaluria Type 1 in the Chinese Population.
    Li X; Gu J; Yang Y; Li J; Li Y
    Tohoku J Exp Med; 2018 Dec; 246(4):233-241. PubMed ID: 30541997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro.
    Lumb MJ; Birdsey GM; Danpure CJ
    Biochem J; 2003 Aug; 374(Pt 1):79-87. PubMed ID: 12737622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of interface mutations on the dimerization of alanine glyoxylate aminotransferase and implications in the mistargeting of the pathogenic variants F152I and I244T.
    Dindo M; Montioli R; Busato M; Giorgetti A; Cellini B; Borri Voltattorni C
    Biochimie; 2016 Dec; 131():137-148. PubMed ID: 27720751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants.
    Coulter-Mackie MB; Lian Q
    Mol Genet Metab; 2008 Jul; 94(3):368-74. PubMed ID: 18448374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.
    Coulter-Mackie MB; Rumsby G; Applegarth DA; Toone JR
    Mol Genet Metab; 2001 Nov; 74(3):314-21. PubMed ID: 11708860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1.
    Kukreja A; Lasaro M; Cobaugh C; Forbes C; Tang JP; Gao X; Martin-Higueras C; Pey AL; Salido E; Sobolov S; Subramanian RR
    Nucleic Acid Ther; 2019 Apr; 29(2):104-113. PubMed ID: 30676254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammalian alanine/glyoxylate aminotransferase 1 is imported into peroxisomes via the PTS1 translocation pathway. Increased degeneracy and context specificity of the mammalian PTS1 motif and implications for the peroxisome-to-mitochondrion mistargeting of AGT in primary hyperoxaluria type 1.
    Motley A; Lumb MJ; Oatey PB; Jennings PR; De Zoysa PA; Wanders RJ; Tabak HF; Danpure CJ
    J Cell Biol; 1995 Oct; 131(1):95-109. PubMed ID: 7559790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria.
    Amoroso A; Pirulli D; Florian F; Puzzer D; Boniotto M; Crovella S; Zezlina S; Spanò A; Mazzola G; Savoldi S; Ferrettini C; Berutti S; Petrarulo M; Marangella M
    J Am Soc Nephrol; 2001 Oct; 12(10):2072-2079. PubMed ID: 11562405
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fetal liver alanine: glyoxylate aminotransferase and the prenatal diagnosis of primary hyperoxaluria type 1.
    Danpure CJ; Jennings PR; Penketh RJ; Wise PJ; Cooper PJ; Rodeck CH
    Prenat Diagn; 1989 Apr; 9(4):271-81. PubMed ID: 2717533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of alanine:glyoxylate aminotransferase 1 dimerization is a prerequisite for its peroxisome-to-mitochondrion mistargeting in primary hyperoxaluria type 1.
    Leiper JM; Oatey PB; Danpure CJ
    J Cell Biol; 1996 Nov; 135(4):939-51. PubMed ID: 8922378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of GroEL in complex with an early folding intermediate of alanine glyoxylate aminotransferase.
    Albert A; Yunta C; Arranz R; Peña A; Salido E; Valpuesta JM; Martín-Benito J
    J Biol Chem; 2010 Feb; 285(9):6371-6. PubMed ID: 20056599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase: study of a spectrum of mutations.
    Coulter-Mackie MB; Lian Q
    Mol Genet Metab; 2006 Dec; 89(4):349-59. PubMed ID: 16971151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Partial deletion of the AGXT gene (EX1_EX7del): A new genotype in hyperoxaluria type 1.
    Nogueira PK; Vuong TS; Bouton O; Maillard A; Marchand M; Rolland MO; Cochat P; Bozon D
    Hum Mutat; 2000 Apr; 15(4):384-5. PubMed ID: 10737993
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural and functional insights on the roles of molecular chaperones in the mistargeting and aggregation phenotypes associated with primary hyperoxaluria type I.
    Fernández-Higuero JÁ; Betancor-Fernández I; Mesa-Torres N; Muga A; Salido E; Pey AL
    Adv Protein Chem Struct Biol; 2019; 114():119-152. PubMed ID: 30635080
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a novel AGXT gene mutation in primary hyperoxaluria after kidney transplantation failure.
    M'dimegh S; Omezzine A; Hamida-Rebai MB; Aquaviva-Bourdain C; M'barek I; Sahtout W; Zellama D; Souche G; Achour A; Abroug S; Bouslama A
    Transpl Immunol; 2016 Nov; 39():60-65. PubMed ID: 27568336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.